These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 14581)

  • 1. Interactions of delta9-tetrahydrocannabinol with other drugs.
    Hollister LE
    Ann N Y Acad Sci; 1976; 281():212-8. PubMed ID: 14581
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of delta9-tetrahydrocannabinol and cannabidiol on a Mg2+-ATPase of synaptic vesicles prepared from rat cerebral cortex.
    Gilbert JC; Pertwee RG; Wyllie MG
    Br J Pharmacol; 1977 Apr; 59(4):599-601. PubMed ID: 139957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.
    Consroe P; Jones B; Laird H
    Ann N Y Acad Sci; 1976; 281():198-211. PubMed ID: 798523
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of cannabinoids and other CNS depressants on cell membrane models.
    Gill EW
    Ann N Y Acad Sci; 1976; 281():151-61. PubMed ID: 14580
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute and subacute interactions between delta9-tetrahydrocannabinol and other drugs in the rat.
    Pryor GT; Husain S; Mitoma C
    Ann N Y Acad Sci; 1976; 281():171-89. PubMed ID: 1071364
    [No Abstract]   [Full Text] [Related]  

  • 6. Interactions of delta9-tetrahydrocannabinol, adrenal steroids, and ethanol.
    List AF; Bartram SF; Nazar BL
    J Pharm Pharmacol; 1975 Aug; 27(8):606-7. PubMed ID: 239177
    [No Abstract]   [Full Text] [Related]  

  • 7. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
    Oviedo A; Glowa J; Herkenham M
    Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible central dopaminergic modulation of the rise in plasma concentration of non-esterified fatty acids produced in the mouse by (-)trans-delta9-tetrahydrocannabinol.
    Malor R; Jackson DM; Chesher GB
    Biochem Pharmacol; 1978 Feb; 27(4):407-13. PubMed ID: 629801
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of delta9-tetrahydrocannabinol with phenobarbital, ethanol and chlordiazepoxide.
    Pryor GT; Larsen FF; Carr JD; Braude MC
    Pharmacol Biochem Behav; 1977 Oct; 7(4):331-45. PubMed ID: 928491
    [No Abstract]   [Full Text] [Related]  

  • 10. Interactions between nicotine and drugs of abuse: a review of preclinical findings.
    Kohut SJ
    Am J Drug Alcohol Abuse; 2017 Mar; 43(2):155-170. PubMed ID: 27589579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of nicotine and cannabinoids on the central nervous system].
    Seutin V
    Rev Med Liege; 2003 Jan; 58(1):19-21. PubMed ID: 12647593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advantages in cannabinoid research.
    Mechoulam R
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():16-20. PubMed ID: 10575284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid influences on palatability: microstructural analysis of sucrose drinking after delta(9)-tetrahydrocannabinol, anandamide, 2-arachidonoyl glycerol and SR141716.
    Higgs S; Williams CM; Kirkham TC
    Psychopharmacology (Berl); 2003 Feb; 165(4):370-7. PubMed ID: 12447606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of inhibition of LHRH release by alcohol and cannabinoids.
    Rettori V; Lomniczi A; Mohn C; Scorticati C; Vissio P; Lasaga M; Franchi A; McCann SM
    Prog Brain Res; 2002; 141():175-81. PubMed ID: 12508569
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study.
    Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L
    Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
    Solinas M; Goldberg SR
    Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of cannabinoids in the treatment of epilepsy.
    Gaston TE; Friedman D
    Epilepsy Behav; 2017 May; 70(Pt B):313-318. PubMed ID: 28087250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice.
    Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF
    J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cannabis in combination with ethanol and other drugs.
    Siemens AJ
    NIDA Res Monogr; 1980; 31():167-98. PubMed ID: 6106899
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of cannabinoids.
    Grotenhermen F
    Clin Pharmacokinet; 2003; 42(4):327-60. PubMed ID: 12648025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.